Sentences with phrase «pelvic organ cross-sensitization»

According to the Food and Drug Administration (FDA), 10 % of women who underwent surgery with transvaginal mesh for pelvic organ prolapse experienced mesh erosion within one year.

Many women who underwent surgery to correct pelvic organ prolapse (POP) or stress urinary incontinence (SUI) were forced to undergo repeat surgeries in order to correct problems with transvaginal mesh.

For women, these products can be permanently implanted to treat stress urinary incontinence (SUI) or pelvic organ prolapse (POP).

Transvaginal or surgical mesh products are used to treat patients with pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

Transvaginal surgical mesh products are used to treat patients who suffer from pelvic organ prolapse or stress urinary incontinence.

Transvaginal mesh is a type of surgical mesh device used for the treatment of pelvic organ prolapse or stress urinary incontinence.

Transvaginal mesh was developed to prevent pelvic organ prolapse and stress urinary incontinence, but thousands of women have since complained that the device migrated or caused other severe side effects.

Transvaginal mesh is used to treat pelvic organ prolapse, which occurs when the pelvic organs bulge through the interior walls of the vagina, and stress urinary incontinence.

Published in the Journal of American Medical Association, the study followed 215 women who received transvaginal mesh to treat pelvic organ prolapse for 7 years.

Patients who received a transvaginal mesh product to treat stress urinary incontinence (SUI) or pelvic organ prolapse (POP) may face a greater risk of complications than patients who received other forms of treatment.

The transvaginal mesh device was originally designed to treat pelvic organ prolapse and stress urinary incontinence, but may have been approved without significant testing.

The Food and Drug Administration (FDA) approved transvaginal mesh to treat stress urinary incontinence and pelvic organ prolapse in 2002 after manufacturers claimed it was similar to hernia mesh.

Trasnvaginal mesh patches were approved to treat conditions such as pelvic organ prolapse (POP) and stress urinary incontinence (SUI), but were soon found to fail and cause patients severe complications.

Used to treat pelvic organ prolapse and stress urinary incontinence, transvaginal mesh was approved after being compared to surgical mesh used to treat hernias.

The company did not disclose how many transvaginal mesh lawsuits the money was intended to settle, though Endo is one of a few companies facing thousands of stress urinary incontinence and pelvic organ prolapse lawsuits.

The three women found each other on the internet after looking for more information on the transvaginal mesh implant, which was intended to prevent pelvic organ prolapse and stress urinary incontinence.

About 1 in 4 women suffer from pelvic organ prolapse or stress urinary incontinence, and between 11 % and 19 % receive mesh surgery to correct it.

FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse, FDA, July 13, 2011

Hundreds of thousands of women have received transvaginal mesh implants to treat stress urinary incontinence and pelvic organ prolapse.

Women who also suffer from pelvic organ prolapse (POP)-- in which the pelvic organs stick out into the vagina — may also experience SUI.

Women who received a transvaginal mesh to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI) have alleged that they suffered severe pain or other complications from the product.

The 3 - year success rates of transvaginal mesh patients were no better than traditional methods of curing pelvic organ prolapse.

Women who received the device to treat pelvic organ prolapse or stress urinary incontinence complained of tissue damage, bleeding, pain and limited mobility due to the transvaginal mesh.

The implanting transvaginal mesh devices was initially seen as an enhanced alternative to tradition surgery to repair POP (pelvic organ prolapse.)

Several top mesh manufacturers have stopped making the surgical mesh, the Food and Drug Administration has ordered additional safety tests and doctors have reduced use of transvaginal mesh to treat pelvic organ prolapse.

These surgical mesh patches can be used during surgery for the treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (POP).

This Food and Drug Administration classification means that complications associated with transvaginal mesh are «not rare» and that there is no evidence proving that transvaginal mesh repair surgeries for pelvic organ prolapse (POP) are more effective than traditional non-mesh repair.

Transvaginal mesh was produced to prevent pelvic organ prolapse and stress urinary incontinence, but studies have since revealed the device may cause more harm than good.

Scottish government figures show several thousand women have received transvaginal mesh implants to treat pelvic organ prolapse and stress urinary incontinence since 2007.

Vaginal mesh devices are used to treat Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP) in women.

The vaginal mesh implant devices have been popular for treating Stress Urinary Incontinence and Pelvic Organ Prolapse.

The transvaginal mesh patch was approved to treat pelvic organ prolapse and stress urinary incontinence, but never underwent serious testing.

FDA Denies Citizen Petition's Request to Ban Marketing of Non-Absorbable Surgical Mesh Products for Transvaginal Repair of Pelvic Organ Prolapse, Natlawreview.com, August 21, 2014

Women diagnosed with pelvic organ prolapse or stress urinary incontinence may have transvaginal mesh devices implanted during surgery to repair the damage.

Transvaginal mesh was approved in 2001 to prevent and treat pelvic organ prolapse, a condition in which pelvic organs bulge through the interior walls of the vagina.

Transvaginal Mesh Devices: These medical devices were introduced on the market as solutions for women who are suffering from pelvic organ prolapse or urinary incontinence.

Transvaginal Mesh is mainly used for treatment of pelvic organ prolapse and stress urinary incontinence.

Boston Scientific's vaginal mesh products are meant to support prolapsed organs and improve symptoms associated with stress urinary incontinence (SUI) and pelvic organ prolapse (POP).

• 4.8 % experienced mesh erosion • 2.4 % experienced painful intercourse • 4 patients developed pelvic abscesses • 7 patients experienced mesh shrinkage The US Food and Drug Administration says vaginal mesh erosion is the most common complication related to this device when used for pelvic organ repair.

FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence, FDA, July 13, 2011

Recently, the FDA made two proposals to tackle the risks involving surgical mesh and its use in transvaginal repair to treat pelvic organ prolapse.

Transvaginal mesh is a medical device implanted surgically to treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI).

In that warning, the FDA also noted that transvaginal mesh devices used to treat pelvic organ prolapse may present risks not associated with more traditional non-mesh surgeries.

Transvaginal mesh — a net - like implant, designed to treat pelvic organ prolapse or stress urinary incontinence, that can cause organ damage, chronic pain, bowel and bladder perforation, vaginal scarring, urinary problems and infections.

The transvaginal mesh devices are used in women who have suffered pelvic organ prolapse (POP).

The medical insertion of mesh has been a regular procedure to repair the muscle damage caused by conditions such as pelvic organ prolapse (POP) or stress urinary incontinence (SUI), and is also commonly used for hernia mesh repair surgeries.

Pelvic organ prolapse occurs when the typical support of the vagina decreases, causing the bladder, urethra, cervix, or rectum to sag or drop.

Pelvic organ prolapse is a condition in which organs in the pelvic region can bulge out of the vagina.

If you or a loved one had surgical mesh implanted for Pelvic Organ Prolapse (POP) or Stress Urinary incontinence (SUI), you may be entitled to compensation for your injuries.

Bard Avaulta Transvaginal Mesh This product is supposed to help a woman suffering from stress urinary incontinence (SUI) and pelvic organ prolapse (POP), hopefully alleviating the discomfort and pain that comes with these conditions.